As we have shown upregulation of the oncomir miR-17∼92 in chronic phase chronic myeloid leukaemia,21 we investigated the role of this cluster in BCR-ABL-positive ALL. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.